# The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization

> **NCT03702244** · NA · COMPLETED · sponsor: **HeartFlow, Inc.** · enrollment: 2103 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DIAGNOSTIC_TEST:** cCTA with selective FFRct

## Key facts

- **NCT ID:** NCT03702244
- **Lead sponsor:** HeartFlow, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-27
- **Primary completion:** 2022-05-20
- **Final completion:** 2022-05-20
- **Target enrollment:** 2103 (ACTUAL)
- **Last updated:** 2023-12-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03702244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03702244, "The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03702244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*